Endocrinology
Conference Coverage
‘Remarkable’ response to diabetes drug in resistant bipolar depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after metformin...
From the Journals
A1c below prediabetes cutoff linked to subclinical atherosclerosis
Hemoglobin A1c below prediabetes levels is a potential biomarker for subclinical atherosclerosis, a European observational study reports.
Conference Coverage
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.
Conference Coverage
‘A better picture’: First AACE guidelines on diabetes technology
Current knowledge on insulin pumps, continuous glucose monitors, automated insulin delivery systems, ‘smart’ pens, telemedicine, apps, and...
Conference Coverage
Daily cup of coffee cuts type 2 diabetes risk by about 5%
Beneficial effects may be caused by coffee’s ability to reduce inflammation.
Conference Coverage
Sotagliflozin’s HFpEF benefit confirmed by new analyses
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
From the Journals
Doctors prescribe fewer statins in the afternoon
News
FDA blazes path for ‘real-world’ evidence as proof of efficacy
FDA leaders must finalize guidance this year on submitting real-world observational evidence for regulatory decisions on drug and device efficacy...
From the Journals
Possible obesity effect detected in cancer death rates
As with heart disease, declines in mortality for some cancers seem to be affected by the obesity epidemic.